Juan C. Jaen Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Juan C. Jaen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Juan C. Jaen. Juan C. Jaen is SVP, Drug Discovery & CSO in ChemoCentryx, Inc. ($CCXI) and President in Arcus Biosciences, Inc. ($RCUS).
Latest Insider Trading Transactions of Juan C. Jaen
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Sell | S | 23.68 | 2,675 | 63,344 | 198,286 | 201 K to 198.3 K (-1.33 %) |
| Jun 21 2021 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Sell | S | 23.68 | 2,675 | 63,344 | 198,286 | 201 K to 198.3 K (-1.33 %) |
| Jun 21 2021 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Sell | S | 24.77 | 87 | 2,155 | 200,961 | 201 K to 201 K (-0.04 %) |
| Jun 21 2021 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Sell | S | 24.77 | 87 | 2,155 | 200,961 | 201 K to 201 K (-0.04 %) |
| Jun 21 2021 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Sell | S | 24.13 | 2,095 | 50,552 | 201,048 | 203.1 K to 201 K (-1.03 %) |
| Jun 21 2021 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Sell | S | 24.13 | 2,095 | 50,552 | 201,048 | 203.1 K to 201 K (-1.03 %) |
| Jan 20 2021 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Option Exercise | A | 36.73 | 116,250 | 4,269,863 | 116,250 | |
| Jan 20 2021 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Grant | A | 0.00 | 19,375 | 0 | 208,768 | 189.4 K to 208.8 K (+10.23 %) |
| Oct 15 2020 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Gift | G | 0.00 | 1,207,000 | 0 | 1,572,240 | 2.8 M to 1.6 M (-43.43 %) |
| Oct 15 2020 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Gift | G | 0.00 | 1,207,000 | 0 | 1,572,240 | 2.8 M to 1.6 M (-43.43 %) |
| Jun 08 2020 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Grant | A | 0.00 | 55,000 | 0 | 244,393 | 189.4 K to 244.4 K (+29.04 %) |
| Jan 22 2020 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Option Exercise | A | 10.23 | 200,000 | 2,046,000 | 200,000 | |
| Jun 28 2019 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Buy | P | 7.89 | 4,894 | 38,637 | 2,779,240 | 2.8 M to 2.8 M (+0.18 %) |
| Jun 28 2019 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Buy | P | 7.44 | 10,106 | 75,217 | 2,774,346 | 2.8 M to 2.8 M (+0.37 %) |
| Jun 04 2019 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Buy | P | 8.25 | 10,000 | 82,485 | 2,764,240 | 2.8 M to 2.8 M (+0.36 %) |
| Jun 04 2019 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Buy | P | 8.25 | 10,000 | 82,485 | 2,764,240 | 2.8 M to 2.8 M (+0.36 %) |
| Jan 18 2019 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Option Exercise | A | 10.36 | 200,000 | 2,072,000 | 200,000 | |
| Aug 13 2018 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Buy | P | 11.77 | 3,159 | 37,168 | 2,744,240 | 2.7 M to 2.7 M (+0.12 %) |
| Aug 13 2018 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Buy | P | 11.94 | 2,579 | 30,796 | 2,741,081 | 2.7 M to 2.7 M (+0.09 %) |
| Aug 13 2018 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Buy | P | 11.93 | 4,262 | 50,855 | 2,738,502 | 2.7 M to 2.7 M (+0.16 %) |
| Mar 19 2018 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Option Exercise | C | 0.00 | 29,936 | 0 | 0 | |
| Mar 19 2018 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Option Exercise | C | 0.00 | 125,012 | 0 | 0 | |
| Mar 19 2018 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Option Exercise | C | 0.00 | 2,020,202 | 0 | 0 | |
| Mar 19 2018 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Buy | P | 15.00 | 66,666 | 999,990 | 2,734,240 | 2.7 M to 2.7 M (+2.50 %) |
| Mar 19 2018 | RCUS | Arcus Biosciences, ... | Jaen Juan C. | President | Buy | C | 0.00 | 2,175,150 | 0 | 2,667,574 | 492.4 K to 2.7 M (+441.72 %) |
| Jul 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | A | 14.28 | 70,000 | 999,600 | 70,000 | |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 13.98 | 2,095 | 29,284 | 30,000 | 32.1 K to 30 K (-6.53 %) |
| Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 13.95 | 700 | 9,765 | 32,095 | 32.8 K to 32.1 K (-2.13 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 13.97 | 4,247 | 59,329 | 32,795 | 37 K to 32.8 K (-11.47 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 13.97 | 2,950 | 41,209 | 37,042 | 40 K to 37 K (-7.38 %) |
| Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 13.96 | 5,008 | 69,935 | 39,992 | 45 K to 40 K (-11.13 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 5,000 | 21,500 | 97,500 | |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 99 | 426 | 102,500 | |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 4,901 | 21,074 | 102,599 | |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 2,599 | 11,176 | 107,500 | |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 13.14 | 5,000 | 65,677 | 45,000 | 50 K to 45 K (-10.00 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,000 | 21,500 | 50,000 | 45 K to 50 K (+11.11 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.56 | 99 | 1,243 | 45,000 | 45.1 K to 45 K (-0.22 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 99 | 426 | 45,099 | 45 K to 45.1 K (+0.22 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.55 | 4,901 | 61,529 | 45,000 | 49.9 K to 45 K (-9.82 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 4,901 | 21,074 | 49,901 | 45 K to 49.9 K (+10.89 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.56 | 2,599 | 32,650 | 45,000 | 47.6 K to 45 K (-5.46 %) |
| Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 2,599 | 11,176 | 47,599 | 45 K to 47.6 K (+5.78 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 2,401 | 10,324 | 110,099 | |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 5,000 | 21,500 | 112,500 | |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 99 | 426 | 117,500 | |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 7,401 | 31,824 | 117,599 | |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 99 | 426 | 125,000 | |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 7,401 | 31,824 | 125,099 | |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 99 | 426 | 132,500 | |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.40 | 2,401 | 29,775 | 45,000 | 47.4 K to 45 K (-5.07 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 2,401 | 10,324 | 47,401 | 45 K to 47.4 K (+5.34 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.35 | 5,000 | 61,772 | 45,000 | 50 K to 45 K (-10.00 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,000 | 21,500 | 50,000 | 45 K to 50 K (+11.11 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.22 | 99 | 1,210 | 45,000 | 45.1 K to 45 K (-0.22 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 99 | 426 | 45,099 | 45 K to 45.1 K (+0.22 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.28 | 7,401 | 90,875 | 45,000 | 52.4 K to 45 K (-14.12 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 7,401 | 31,824 | 52,401 | 45 K to 52.4 K (+16.45 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.04 | 99 | 1,192 | 45,000 | 45.1 K to 45 K (-0.22 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 99 | 426 | 45,099 | 45 K to 45.1 K (+0.22 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.05 | 7,401 | 89,206 | 45,000 | 52.4 K to 45 K (-14.12 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 7,401 | 31,824 | 52,401 | 45 K to 52.4 K (+16.45 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.89 | 99 | 1,177 | 45,000 | 45.1 K to 45 K (-0.22 %) |
| Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 99 | 426 | 45,099 | 45 K to 45.1 K (+0.22 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 1,100 | 4,730 | 132,599 | |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 5,601 | 24,084 | 133,699 | |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 700 | 3,010 | 139,300 | |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 6,800 | 29,240 | 140,000 | |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.89 | 1,100 | 13,079 | 45,000 | 46.1 K to 45 K (-2.39 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,100 | 4,730 | 46,100 | 45 K to 46.1 K (+2.44 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.90 | 5,601 | 66,633 | 45,000 | 50.6 K to 45 K (-11.07 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,601 | 24,084 | 50,601 | 45 K to 50.6 K (+12.45 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.95 | 8,000 | 95,600 | 45,000 | 53 K to 45 K (-15.09 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.85 | 700 | 8,295 | 53,000 | 53.7 K to 53 K (-1.30 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 700 | 3,010 | 53,700 | 53 K to 53.7 K (+1.32 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.86 | 6,800 | 80,640 | 53,000 | 59.8 K to 53 K (-11.37 %) |
| Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 6,800 | 29,240 | 59,800 | 53 K to 59.8 K (+12.83 %) |
| Feb 19 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 700 | 3,010 | 146,800 | |
| Feb 19 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 1,245 | 5,354 | 147,500 | |
| Feb 19 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.78 | 700 | 8,244 | 53,000 | 53.7 K to 53 K (-1.30 %) |
| Feb 19 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 700 | 3,010 | 53,700 | 53 K to 53.7 K (+1.32 %) |
| Feb 19 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.71 | 1,245 | 14,581 | 53,000 | 54.2 K to 53 K (-2.30 %) |
| Feb 19 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,245 | 5,354 | 54,245 | 53 K to 54.2 K (+2.35 %) |
| Feb 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 3,100 | 13,330 | 150,300 | |
| Feb 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 775 | 3,333 | 153,400 | |
| Feb 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.69 | 3,100 | 36,254 | 53,000 | 56.1 K to 53 K (-5.53 %) |
| Feb 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 3,100 | 13,330 | 56,100 | 53 K to 56.1 K (+5.85 %) |
| Feb 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.67 | 775 | 9,041 | 53,000 | 53.8 K to 53 K (-1.44 %) |
| Feb 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 775 | 3,333 | 53,775 | 53 K to 53.8 K (+1.46 %) |
| Feb 08 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 1,555 | 6,687 | 148,745 | |
| Feb 08 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.65 | 1,555 | 18,116 | 53,000 | 54.6 K to 53 K (-2.85 %) |
| Feb 08 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,555 | 6,687 | 54,555 | 53 K to 54.6 K (+2.93 %) |
| Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 6,725 | 28,918 | 154,175 | |
| Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 3,280 | 14,104 | 160,900 | |
| Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.65 | 1,600 | 18,640 | 53,000 | 54.6 K to 53 K (-2.93 %) |
| Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,600 | 6,880 | 54,600 | 53 K to 54.6 K (+3.02 %) |
| Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.60 | 5,125 | 59,466 | 53,000 | 58.1 K to 53 K (-8.82 %) |
| Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,125 | 22,038 | 58,125 | 53 K to 58.1 K (+9.67 %) |
| Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.57 | 1,600 | 18,516 | 53,000 | 54.6 K to 53 K (-2.93 %) |
| Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,600 | 6,880 | 54,600 | 53 K to 54.6 K (+3.02 %) |
| Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.45 | 1,680 | 19,236 | 53,000 | 54.7 K to 53 K (-3.07 %) |
| Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,680 | 7,224 | 54,680 | 53 K to 54.7 K (+3.17 %) |
| Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 4,892 | 21,036 | 164,180 | |
| Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 2,710 | 11,653 | 169,072 | |
| Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 96 | 413 | 171,782 | |
| Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.45 | 4,892 | 56,013 | 53,000 | 57.9 K to 53 K (-8.45 %) |
| Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 4,892 | 21,036 | 57,892 | 53 K to 57.9 K (+9.23 %) |
| Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.45 | 928 | 10,626 | 53,000 | 53.9 K to 53 K (-1.72 %) |
| Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 928 | 3,990 | 53,928 | 53 K to 53.9 K (+1.75 %) |
| Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 1,782 | 20,226 | 53,000 | 54.8 K to 53 K (-3.25 %) |
| Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,782 | 7,663 | 54,782 | 53 K to 54.8 K (+3.36 %) |
| Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 96 | 1,090 | 53,000 | 53.1 K to 53 K (-0.18 %) |
| Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 96 | 413 | 53,096 | 53 K to 53.1 K (+0.18 %) |
| Jan 24 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 1,200 | 5,160 | 171,878 | |
| Jan 24 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 100 | 430 | 173,078 | |
| Jan 24 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 1,200 | 13,622 | 53,000 | 54.2 K to 53 K (-2.21 %) |
| Jan 24 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,200 | 5,160 | 54,200 | 53 K to 54.2 K (+2.26 %) |
| Jan 24 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 100 | 1,135 | 53,000 | 53.1 K to 53 K (-0.19 %) |
| Jan 24 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 100 | 430 | 53,100 | 53 K to 53.1 K (+0.19 %) |
| Jan 15 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 3,305 | 14,212 | 173,178 | |
| Jan 15 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 3,305 | 37,512 | 53,000 | 56.3 K to 53 K (-5.87 %) |
| Jan 15 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 3,305 | 14,212 | 56,305 | 53 K to 56.3 K (+6.24 %) |
| Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 96 | 413 | 176,483 | |
| Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 100 | 430 | 176,579 | |
| Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 5,821 | 25,030 | 176,679 | |
| Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 96 | 1,090 | 53,000 | 53.1 K to 53 K (-0.18 %) |
| Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 96 | 413 | 53,096 | 53 K to 53.1 K (+0.18 %) |
| Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 100 | 1,135 | 53,000 | 53.1 K to 53 K (-0.19 %) |
| Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 100 | 430 | 53,100 | 53 K to 53.1 K (+0.19 %) |
| Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 821 | 9,318 | 53,000 | 53.8 K to 53 K (-1.53 %) |
| Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 821 | 3,530 | 53,821 | 53 K to 53.8 K (+1.55 %) |
| Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.25 | 5,000 | 56,250 | 53,000 | 58 K to 53 K (-8.62 %) |
| Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,000 | 21,500 | 58,000 | 53 K to 58 K (+9.43 %) |
| Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 7,500 | 32,250 | 182,500 | |
| Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 7,500 | 32,250 | 190,000 | |
| Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.05 | 2,500 | 27,625 | 53,000 | 55.5 K to 53 K (-4.50 %) |
| Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 2,500 | 10,750 | 55,500 | 53 K to 55.5 K (+4.72 %) |
| Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.15 | 5,000 | 55,750 | 53,000 | 58 K to 53 K (-8.62 %) |
| Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,000 | 21,500 | 58,000 | 53 K to 58 K (+9.43 %) |
| Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.05 | 2,500 | 27,625 | 53,000 | 55.5 K to 53 K (-4.50 %) |
| Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 2,500 | 10,750 | 55,500 | 53 K to 55.5 K (+4.72 %) |
| Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 10.95 | 5,000 | 54,750 | 53,000 | 58 K to 53 K (-8.62 %) |
| Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,000 | 21,500 | 58,000 | 53 K to 58 K (+9.43 %) |
| Nov 16 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.95 | 2,000 | 25,900 | 53,000 | 55 K to 53 K (-3.64 %) |
| Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.01 | 5,833 | 70,030 | 55,000 | 60.8 K to 55 K (-9.59 %) |
| Oct 01 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.98 | 2,100 | 25,157 | 60,833 | 62.9 K to 60.8 K (-3.34 %) |
| Oct 01 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.95 | 300 | 3,586 | 62,933 | 63.2 K to 62.9 K (-0.47 %) |
| Sep 27 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.96 | 7,401 | 88,480 | 63,233 | 70.6 K to 63.2 K (-10.48 %) |
| Sep 24 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.96 | 2,705 | 32,358 | 70,634 | 73.3 K to 70.6 K (-3.69 %) |
| Sep 24 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.01 | 200 | 2,402 | 73,339 | 73.5 K to 73.3 K (-0.27 %) |